X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs CIPLA - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON CIPLA BIOCON /
CIPLA
 
P/E (TTM) x 41.0 35.1 116.9% View Chart
P/BV x 7.1 3.2 224.3% View Chart
Dividend Yield % 0.2 0.5 30.4%  

Financials

 BIOCON    CIPLA
EQUITY SHARE DATA
    BIOCON
Mar-18
CIPLA
Mar-18
BIOCON /
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,188663 179.2%   
Low Rs305479 63.7%   
Sales per share (Unadj.) Rs68.7189.0 36.4%  
Earnings per share (Unadj.) Rs7.617.6 42.9%  
Cash flow per share (Unadj.) Rs14.034.0 41.1%  
Dividends per share (Unadj.) Rs1.003.00 33.3%  
Dividend yield (eoy) %0.10.5 25.5%  
Book value per share (Unadj.) Rs86.3176.7 48.9%  
Shares outstanding (eoy) m600.00805.12 74.5%   
Bonus/Rights/Conversions ISESOP-  
Price / Sales ratio x10.93.0 359.6%   
Avg P/E ratio x98.932.5 304.6%  
P/CF ratio (eoy) x53.416.8 318.4%  
Price / Book Value ratio x8.63.2 267.6%  
Dividend payout %13.217.1 77.7%   
Avg Mkt Cap Rs m447,900459,724 97.4%   
No. of employees `0006.123.6 26.0%   
Total wages/salary Rs m9,31126,901 34.6%   
Avg. sales/employee Rs Th6,705.86,446.1 104.0%   
Avg. wages/employee Rs Th1,514.21,139.4 132.9%   
Avg. net profit/employee Rs Th736.9600.0 122.8%   
INCOME DATA
Net Sales Rs m41,234152,193 27.1%  
Other income Rs m2,0623,577 57.7%   
Total revenues Rs m43,296155,769 27.8%   
Gross profit Rs m8,29128,264 29.3%  
Depreciation Rs m3,85113,228 29.1%   
Interest Rs m6151,142 53.8%   
Profit before tax Rs m5,88717,470 33.7%   
Minority Interest Rs m2130-   
Prior Period Items Rs m0-28 0.0%   
Extraordinary Inc (Exp) Rs m0-775 0.0%   
Tax Rs m1,5692,501 62.7%   
Profit after tax Rs m4,53114,166 32.0%  
Gross profit margin %20.118.6 108.3%  
Effective tax rate %26.714.3 186.2%   
Net profit margin %11.09.3 118.1%  
BALANCE SHEET DATA
Current assets Rs m41,486108,141 38.4%   
Current liabilities Rs m21,41338,322 55.9%   
Net working cap to sales %48.745.9 106.1%  
Current ratio x1.92.8 68.7%  
Inventory Days Days6497 65.9%  
Debtors Days Days9474 126.6%  
Net fixed assets Rs m50,661109,411 46.3%   
Share capital Rs m3,0001,610 186.3%   
"Free" reserves Rs m48,808140,682 34.7%   
Net worth Rs m51,808142,292 36.4%   
Long term debt Rs m17,89836,621 48.9%   
Total assets Rs m99,897228,606 43.7%  
Interest coverage x10.616.3 64.9%   
Debt to equity ratio x0.30.3 134.2%  
Sales to assets ratio x0.40.7 62.0%   
Return on assets %5.26.7 76.9%  
Return on equity %8.710.0 87.8%  
Return on capital %9.610.0 96.8%  
Exports to sales %032.8 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA49,883 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,05851,691 23.3%   
Fx outflow Rs m7,34821,033 34.9%   
Net fx Rs m4,71030,658 15.4%   
CASH FLOW
From Operations Rs m6,62114,628 45.3%  
From Investments Rs m-6,840-8,540 80.1%  
From Financial Activity Rs m-2,397-3,855 62.2%  
Net Cashflow Rs m-2,6122,431 -107.4%  

Share Holding

Indian Promoters % 40.4 16.0 252.5%  
Foreign collaborators % 20.6 20.8 99.0%  
Indian inst/Mut Fund % 8.4 12.2 68.9%  
FIIs % 10.7 23.7 45.1%  
ADR/GDR % 0.0 1.1 -  
Free float % 19.9 26.2 76.0%  
Shareholders   109,995 161,166 68.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   CADILA HEALTHCARE  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  NATCO PHARMA  DIVIS LABORATORIES  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

CIPLA Announces Quarterly Results (3QFY19); Net Profit Up 17.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, CIPLA has posted a net profit of Rs 3 bn (up 17.5% YoY). Sales on the other hand came in at Rs 40 bn (up 2.4% YoY). Read on for a complete analysis of CIPLA's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

CIPLA Announces Quarterly Results (2QFY19); Net Profit Down 15.8% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, CIPLA has posted a net profit of Rs 4 bn (down 15.8% YoY). Sales on the other hand came in at Rs 40 bn (down 1.7% YoY). Read on for a complete analysis of CIPLA's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

CIPLA Announces Quarterly Results (1QFY19); Net Profit Up 4.7% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, CIPLA has posted a net profit of Rs 4 bn (up 4.7% YoY). Sales on the other hand came in at Rs 39 bn (up 11.7% YoY). Read on for a complete analysis of CIPLA's quarterly results.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Apr 18, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS